Back
Revance Therapeutics Vs. Recursion Pharmaceuticals Industry Stock Comparison
Sell
13
RVNC
Revance Therapeutics
Last Price:
$3.09
Seasonality Move:
-2.77%
Sell
18
RXRX
Recursion Pharmaceuticals
Last Price:
$6.05
Seasonality Move:
-18.3%
Sell
13
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
-
The current Revance Therapeutics [RVNC] share price is $3.08. The Score for RVNC is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
18
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
-
The current Recursion Pharmaceuticals [RXRX] share price is $6.04. The Score for RXRX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
RXRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $3.08The current trend is relatively stagnant and RVNC is experiencing slight buying pressure.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $6.04Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight selling pressure.
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.38 | Sell |
Relative Strength Index (14 RSI): | 33.1 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.14 - 3.96) | Sell |
Bollinger Bands (100): | (3.74 - 6.28) | Sell |
RXRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 41.96 | Sell |
Chaikin Money Flow: | -4377360 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6 - 7.44) | Sell |
Bollinger Bands (100): | (6.19 - 7.31) | Sell |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.07 | Buy |
20-day SMA: | 3.46 | Sell |
50-day SMA: | 4.37 | Sell |
200-day SMA: | 4.37 | Sell |
8-day EMA: | 3.14 | Sell |
20-day EMA: | 3.46 | Sell |
50-day EMA: | 4.1 | Sell |
200-day EMA: | 5.56 | Sell |
RXRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.8 | Sell |
20-day SMA: | 6.88 | Sell |
50-day SMA: | 6.75 | Sell |
200-day SMA: | 7.8 | Sell |
8-day EMA: | 6.64 | Sell |
20-day EMA: | 6.82 | Sell |
50-day EMA: | 6.81 | Sell |
200-day EMA: | 7.55 | Sell |
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.63 per share.
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.
Revance Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Recursion Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |